Opening book details…
Can I read Initial Clinical Experience with High-Dose Rate Intracavitary Brachytherapy Using the MammoSite® and ConturaTM Devices for the Treatment of High-Grade Glioma on EtoBox?
Initial Clinical Experience with High-Dose Rate Intracavitary Brachytherapy Using the MammoSite® and ConturaTM Devices for the Treatment of High-Grade Glioma by Brent S. Rose; Daniel J. Scanderbeg; Joshua D. Lawson; Sameer K. Nath; John F. Alksne; Kevin T. Murphy is a Medicine article available to read on EtoBox.
What is Initial Clinical Experience with High-Dose Rate Intracavitary Brachytherapy Using the MammoSite® and ConturaTM Devices for the Treatment of High-Grade Glioma about?
reached). The overall survival and disease-free survival at 38 months was 85.7% and 84.6%, respectively. No radiation related toxicities were observed. Three patients had air-leaks that resolved and only 1 patient had a postoperative infection that also resolved. No late toxicities (O3 months after surgery) were seen. Conclusions: Though our results are early, it appears that 125 I mesh brachytherapy is a reasonable option for patients with stage I NSCLC that cannot undergo lobectomy. The high local control suggests this may be reasonable option for patients with medically operable disease and prospective studies are currently under development.
Who reads Initial Clinical Experience with High-Dose Rate Intracavitary Brachytherapy Using the MammoSite® and ConturaTM Devices for the Treatment of High-Grade Glioma?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Brent S. Rose; Daniel J. Scanderbeg; Joshua D. Lawson; Sameer K. Nath; John F. Alksne; Kevin T. Murphy
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 1538-4721)
- Published
- 2010
- Language
- EN
- Field
- Medicine (Health Sciences)